生物降解和生物相容的合成聚合物的最新进展用于皮肤伤口愈合
Ruojiao Xu1, Yifeng Fang1, Zhao Zhang1
1College of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Materials (Basel, Switzerland)
|August 12, 2023
概括
合成可生物降解聚合物为皮肤伤口带提供了先进的解决方案,克服了天然材料的局限性. 这些聚合物促进伤口愈合和皮肤恢复,为改进的治疗铺平了道路.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 再生医学是一种再生医学.
背景情况:
- 皮肤伤口治疗由于创伤和疾病而面临挑战,造成全球经济负担.
- 像原蛋白和氨酸这样的天然聚合物表现有希望,但有局限性 (机械性能差,降解速度快).
- 可生物降解的合成聚合物为先进的伤口包装材料提供了优越的替代品.
研究的目的:
- 审查可生物降解和生物相容的合成聚合物用于皮肤伤口包裹.
- 专注于它们的组成,制造和伤口愈合功能.
- 探索基于合成聚合物的伤口包裹的未来前景.
主要方法:
- 对用于伤口包裹的合成聚合物进行文献综述.
- 分析聚合物组成和制造技术.
- 评估聚合物在促进伤口愈合方面的功能.
主要成果:
- 确定了主要的合成聚合物:PVA,PCL,PLA,PLGA,PU,PEO/PEG.
- 详细介绍了它们的特性,制造方法和伤口愈合机制.
- 突出了与天然聚合物对伤口护理的优势.
结论:
- 合成可生物降解聚合物对先进的皮肤伤口带有前途.
- 这些材料提供了更好的机械性能和受控的降解.
- 进一步开发对于优化基于合成聚合物的伤口护理解决方案至关重要.
相关概念视频
Phases of Wound Repair
6.1K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
6.1K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


